Tech Company Financing Transactions

Lutonix Funding Round

Lutonix closed a $20 million Series B investment round on 10/27/2008. Investors included Versant Ventures, Delphi Ventures and RiverVest Venture Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Medical Devices & Instruments

Mailing Address

7351 Kirkwood Lane North 138
Maple Grove, MN 55369
USA

Phone

(763) 445-2352

Website

www.lutonix.com

Email Address

[email protected]

Overview

The Vision of Lutonix is to improve the quality of life for patients with vascular disease through innovative solutions.The Mission of Lutonix is to rapidly develop and commercialize the safest and most efficacious drug coated balloon catheters for treatment of vascular disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dennis Wahr

        

Chief Scientific Officer

Scott Naisbitt

        

Chief Technical Officer

Lixiao Wang

        

VP - Finance

Kari Kubesh

        

VP - R & D

Chris Barry

        

VP - Regulatory Affairs

Debra Lano

        

Browse more venture capital transactions:

Prev: 10/27/2008: InfaCare Pharmaceutical venture capital transaction
Next: 10/27/2008: Digital Performance venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary